SRTA Stock Analysis: Buy, Sell, or Hold?
SRTA - Strata Critical Medical, Inc. Class A Common Stock
$4.88
-0.19 (-3.75%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 12, 2026
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SRTA is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SRTA is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $4.88, which is considered oversold relative to its 30-day fair value range of $5.01 to $5.77. The stock's valuation (Forward PE: 61.0) is in line with its historical norms (64.3). Remarkably, the market is currently pricing in an annual earnings decline of 1.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SRTA is in a uptrend. The price is currently testing key support at $4.85. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.25 (+89.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRTA is in a uptrend. The price is currently testing key support at $4.85. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.25 (+89.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$5.01 -
$5.77
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Protect Your Profits
Holding SRTA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 89.5% below Wall St target ($9.25)
- WARNING: Recommendation downgraded due to -10.8% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$5.01 -
$5.77
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$4.85
Resistance Level
$6.00
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
61.00
Wall Street Target
$9.25
(+89.5%)
Revenue Growth (YoY)
208.3%
Profit Margin
-55.0%
Valuation Discount vs History
-1.7% cheaper
PE vs Historical
61.0 vs 64.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.7%
(market-implied from PE analysis)
1-Year Target
$4.80
(-2%)
2-Year Target
$4.72
(-3%)
3-Year Target
$4.64
(-5%)
3-Yr Target (if PE normalizes)
(PE: 61→64)
$4.89
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 61.0 to 64.3
Stabilization Target:
$5.14
(+5.4%)
PE Expansion Potential:
+5.4%
Last updated: February 01, 2026 9:51 AM ET
Data refreshes hourly during market hours. Next update: 10:51 AM
Data refreshes hourly during market hours. Next update: 10:51 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$529 | 63 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$238 | 54 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$140 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$17 | 52 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$28 | 62 BUY |
Advanced SRTA Option Strategies
Professional options setups generated by AI based on today's SRTA price and gamma walls.